Compare Costco Wholesale Corporation (COST) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Johnson & Johnson — how do they compare? Costco Wholesale Corporation trades at $916.3 (market cap $408.78B), while Johnson & Johnson trades at $247.4 (market cap $611.07B). The key difference: Johnson & Johnson is the larger of the two by market cap, and Johnson & Johnson pays the higher dividend (2.11%). Which is the better fit depends on your goals.
| COST | JNJ | |
|---|---|---|
Market Cap | $408.78B | $611.07B |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $267.24 |
52-Week Low | $849.63 | $155.17 |
Enterprise Value | $396.92B | $644.01B |
Dividend Yield | 0.64% | 2.11% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $916.54, down 1.07% with a bearish technical signal. The company shows strong fundamentals with revenue growth from $275.24B in 2025 to projected $293.6B in 2026 and consistent earnings beats in recent quarters. Analyst consensus remains strongly bullish with 65.5% buy ratings and a $1,120 price target, though valuation metrics appear elevated with a P/E of 46.37. Recent March sales surged 11.3% year-over-year, demonstrating resilient consumer demand despite market volatility.
The outlook remains positive given Costco's membership fee growth and expansion strategy, but risks include premium valuation compression and competitive pressures. With strong institutional accumulation and solid cash flow generation, COST offers long-term growth potential for investors comfortable with current multiples. The stock's current pullback near support at $917 may present an entry opportunity for patient investors.
Johnson & Johnson (JNJ) trades at $257.77, up 0.31% with a bullish technical signal and strong institutional support. The stock shows robust fundamentals with 2025 revenue of $94.19B, net income margin of 21.83%, and consistent earnings beats. Recent dividend declaration of $1.34 and positive analyst coverage with 52.5% buy ratings reinforce confidence. The current price sits near pivot point resistance at $258, with technical indicators showing bullish momentum from moving averages.
JNJ presents a compelling long-term investment with stable cash flows, strong profitability metrics, and defensive healthcare positioning. Upside potential exists toward the $281 consensus price target, though risks include rising debt-to-asset ratio (24.06% in 2025) and patent expiration headwinds. The stock's 60+ year dividend growth history provides income stability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
